The European Valve Durability TAVI Registry highlights the long-term performance of TAVI. The incidence of moderate or severe structural valve deterioration (SVD) during long-term follow-up was relatively low, with severe SVD being even rarer than moderate SVD. SVD occurred more

This #JACCINT analysis assessed midframe underexpansion after #TAVR with the self-expanding ACURATE neo2 valve and found it occurred in 13.9% of patients. Midframe underexpansion was associated with higher 1-year mortality, stroke, and rehospitalization. https://t.co/5mIhYsSE8R

And here are finally the 5-year results of Evolut Low Risk, a trial in which the self-expanding prosthesis holds its own against surgery. A trial where, let’s remember, the average age was 74 years. For years, to the question: 'How long does a TAVI prosthesis last?' we didn’t

Dr. @MReardon19 on the EVOLUT Low Risk trial: 📌 Low surgical risk patients with severe AS who were treated with either Evolut or surgery showed comparable rates of all-cause mortality or disabling #stroke at 5 years (15.5% Evolut and 16.4% surgery, p=0.47) #ACC25 #JACC #SAVR

#ACC25 #Evolut low rish : low surgical risk pts with severe AS —> Evolut vs surgery —> comparable rates of all-cause mortality or disabling stroke at 5 years (15.5% Evolut and 16.4% surgery, p=0.47) @Mod_Pharmacist @KimMed_ @RThachilMD @PA_Kotta @ujebubechukwu @Ibrahim_Kamel9

Dr. @MReardon19 on the EVOLUT Low Risk trial: The results of the trial at 5 years support Evolut as a safe, effective, and durable alternative to surgery for patients with severe aortic stenosis and low surgical risk #ACC25 #TAVR #SAVR #vhdAS #cvSurg #JACC

Chronic Total Occlusion PCI in diabetes at @CRT_meeting

ICYMI: 5-yr valve performance is significantly better after CoreValve/Evolut #TAVI compared to surgery. The development of BVD in TAVI and surgery patients was associated with worsened 5-yr clinical outcomes. https://t.co/QAX6Rnh6EY #CRT2025 #JACC #cvSurg @aakriti_15 @MReardon19

Congrats to Howard Herrmann, @Drroxmehran @didier_tchetche and #SMART trial investigators for outstanding 2y data and outcomes #CRT2025, with excellent clinical and echo follow up! While no differences in hard endpoints (no surprise), what struck me the most is the adjudicated

Thank you my friend ⁦@StevenYakubov⁩ for this nice podcast in which we talk about life, career, hard work and coronary access post #TAVR

Great Canadian #TAVI implanters meeting last weekend in Montreal. Outstanding atmosphere led by my friends Nico Piazza and Sam Radhakrishnan…and @erichorlick showed not only his superb cardiology knowledge but also that nobody knows submarine movies like him😉 @RodrigoBagur

@ShariqShamimMD Read our CANNULATE TAVR study on JACC Intv on consecutive (no selection for easier anatomies) patients for 100% coronary cannulation post TAVR with FX. You can also attend our late breaking trial presentation at London Valves for the CANNULATE TAVR EXTENDED and simultaneous paper

Just presented 1y full TRILUMINATR RCT #T-TEER TriClip system for severe TR. ⬆️WINs, KCCQ 6MWD. Congrats to all co authors and now published in @JACCJournals @hahn_rt @psorajja @HamidNadira @AbbottCardio #TCT2024 @crfheart @TCTMD

Packed best global research in TAVR session during the very first hour of #TCT2024. Great discussion on coronary re-access and looking forward to CANULATE TRIAL to be presented during #PCRLV24 @GuiAttizzaniMD @OhnoTuri @ACUkaigweMD @shishem @HarringtonHVI

Great sessions at @crfheart #TCT2024

Nice discussion about coronary cannulation post-#TAVR with my brother @OhnoTuri and Prof Hyo-Soo Kim starting #ENCORE Congress in Seoul. Great to meet our friend @DFCapodanno for dinner remembering our fellowship days in Italy @FrazzettoMarco

Looking forward to exciting discussions on complex #TAVI cases and a lot of learning! ⁦@UHhospitals⁩ ⁦@MDT_StructHeart⁩ ⁦@vinesteves⁩ ⁦@ACUkaigweMD⁩ ⁦@HarringtonHVI⁩ ⁦@shishem⁩ ⁦@SMPatelMD⁩ ⁦@FrazzettoMarco⁩

What A Milestone for both of us! August 21st 2024, I proctored my mentor Dr. Strickman (who taught me TAVR 10 years ago as a fellow at THI), he performed his first Evolut FX plus TAVR case, I am so glad I was able to help, I still look up to him and learn from his wisdom, courage

Moderating 4 Live TAVR Evolut cases from Australia 🇦🇺, Taiwan 🇹🇼, Brazil 🇧🇷 & Argentina 🇦🇷 was a great fun alongside @AntoniousAttall In-person discussions & debates about #TAVR latest data & best practices among implanters from different 12 nations (aside from US) Thanks to

Nice transmission last Friday to 🇺🇸 using the excellent MEDINBOX AIR portable system !! Great case with a lot of discussion on small annulus anatomies. @GuiAttizzaniMD @Almanfi_Cardio @medinbox @modine_thomas @didier_tchetche @msztejfman @JGMD63 @NicoGausserand